Cargando…

Natural plant products in treatment of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a severe disease characterized by progressive remodeling of distal pulmonary arteries and persistent elevation of pulmonary vascular resistance (PVR), which leads to right ventricular dysfunction, heart failure, and eventually death. Although treatment respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Lili, Li, Ying, Deng, Xu, Kosanovic, Djuro, Schermuly, Ralph Theo, Li, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055327/
https://www.ncbi.nlm.nih.gov/pubmed/29869936
http://dx.doi.org/10.1177/2045894018784033
_version_ 1783341149525639168
author Xiang, Lili
Li, Ying
Deng, Xu
Kosanovic, Djuro
Schermuly, Ralph Theo
Li, Xiaohui
author_facet Xiang, Lili
Li, Ying
Deng, Xu
Kosanovic, Djuro
Schermuly, Ralph Theo
Li, Xiaohui
author_sort Xiang, Lili
collection PubMed
description Pulmonary arterial hypertension (PAH) is a severe disease characterized by progressive remodeling of distal pulmonary arteries and persistent elevation of pulmonary vascular resistance (PVR), which leads to right ventricular dysfunction, heart failure, and eventually death. Although treatment responsiveness for this disease is improving, it continues to be a life-threatening condition. With the clinical efficacy of natural plant products being fully confirmed by years of practice, more and more recognition and attention have been obtained from the international pharmaceutical industry. Moreover, studies over the past decades have demonstrated that drugs derived from natural plants show unique advantages and broad application prospects in PAH treatment, not to mention the historical application of Chinese traditional medicine in cardiopulmonary diseases. In this review, we focus on summarizing natural plant compounds with therapeutic properties in PAH, according to the extracts, fractions, and pure compounds from plants into categories, hoping it to be helpful for basic research and clinical application.
format Online
Article
Text
id pubmed-6055327
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-60553272018-07-25 Natural plant products in treatment of pulmonary arterial hypertension Xiang, Lili Li, Ying Deng, Xu Kosanovic, Djuro Schermuly, Ralph Theo Li, Xiaohui Pulm Circ Review Article Pulmonary arterial hypertension (PAH) is a severe disease characterized by progressive remodeling of distal pulmonary arteries and persistent elevation of pulmonary vascular resistance (PVR), which leads to right ventricular dysfunction, heart failure, and eventually death. Although treatment responsiveness for this disease is improving, it continues to be a life-threatening condition. With the clinical efficacy of natural plant products being fully confirmed by years of practice, more and more recognition and attention have been obtained from the international pharmaceutical industry. Moreover, studies over the past decades have demonstrated that drugs derived from natural plants show unique advantages and broad application prospects in PAH treatment, not to mention the historical application of Chinese traditional medicine in cardiopulmonary diseases. In this review, we focus on summarizing natural plant compounds with therapeutic properties in PAH, according to the extracts, fractions, and pure compounds from plants into categories, hoping it to be helpful for basic research and clinical application. SAGE Publications 2018-06-05 /pmc/articles/PMC6055327/ /pubmed/29869936 http://dx.doi.org/10.1177/2045894018784033 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review Article
Xiang, Lili
Li, Ying
Deng, Xu
Kosanovic, Djuro
Schermuly, Ralph Theo
Li, Xiaohui
Natural plant products in treatment of pulmonary arterial hypertension
title Natural plant products in treatment of pulmonary arterial hypertension
title_full Natural plant products in treatment of pulmonary arterial hypertension
title_fullStr Natural plant products in treatment of pulmonary arterial hypertension
title_full_unstemmed Natural plant products in treatment of pulmonary arterial hypertension
title_short Natural plant products in treatment of pulmonary arterial hypertension
title_sort natural plant products in treatment of pulmonary arterial hypertension
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055327/
https://www.ncbi.nlm.nih.gov/pubmed/29869936
http://dx.doi.org/10.1177/2045894018784033
work_keys_str_mv AT xianglili naturalplantproductsintreatmentofpulmonaryarterialhypertension
AT liying naturalplantproductsintreatmentofpulmonaryarterialhypertension
AT dengxu naturalplantproductsintreatmentofpulmonaryarterialhypertension
AT kosanovicdjuro naturalplantproductsintreatmentofpulmonaryarterialhypertension
AT schermulyralphtheo naturalplantproductsintreatmentofpulmonaryarterialhypertension
AT lixiaohui naturalplantproductsintreatmentofpulmonaryarterialhypertension